Robert Haber, MD
Dermatology · Beachwood, OHNPI 1346233160
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 302 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations.
Across 302 payments — averaging $19.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$1K
- Galderma Laboratories, L.p.$664
- Lilly USA, LLC$517
- AbbVie$458
- Johnson & Johnson$366
- UCB, Inc.$313
- plus $3K from 26 others
Across 70 payments — averaging $2396.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Aclaris Therapeutics, Inc.$61K
- Sun Pharmaceutical Industries Inc.$39K
- Journey Medical Corporation$26K
- Taro Pharmaceuticals USA, Inc.$14K
- Dr.reddy's Laboratories,inc.$12K
- Novartis$9K
- plus $7K from 1 others
What the payments were for
- Food & beverage$5,89599%
- Education$821%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 52 | $1,083 |
| Galderma Laboratories, L.p. | 42 | $664 |
| Lilly USA, LLC | 25 | $517 |
| AbbVie(2 entities) | 27 | $458 |
| Johnson & Johnson | 20 | $366 |
| UCB, Inc. | 15 | $313 |
| Sanofi | 13 | $279 |
| Pfizer | 16 | $228 |
| Incyte Corporation | 10 | $207 |
| Amgen | 10 | $198 |
| Regeneron Healthcare Solutions, Inc. | 10 | $182 |
| Novartis | 7 | $167 |
| Revance Therapeutics, Inc. | 4 | $164 |
| EPI Health, LLC | 3 | $151 |
| Dermavant Sciences, Inc. | 7 | $148 |
| Eli Lilly | 1 | $125 |
| VYNE Pharmaceuticals Inc. | 5 | $112 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $98 |
| E.r. Squibb & Sons, L.L.C. | 3 | $65 |
| Organon | 5 | $56 |
| Strata Skin Sciences, Inc. | 5 | $54 |
| Convatec Inc. | 2 | $52 |
| Organogenesis Inc. | 1 | $51 |
| LEO Pharma Inc. | 2 | $47 |
| Mayne Pharma Commercial LLC | 2 | $42 |
| Medimetriks Pharmaceuticals, Inc. | 3 | $38 |
| Bristol Myers Squibb | 1 | $24 |
| Nobelpharma America, LLC | 1 | $20 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $17 |
| Arcutis Biotherapeutics, Inc. | 1 | $17 |
| Novum Pharma, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,977 in reported general payments places this provider in the 65th percentile of 460 dermatology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Minoxidil | 448 | $2,611 |
| Triamcinolone Acetonide | 88 | $2,034 |
| Finasteride | 146 | $1,589 |
| Desonide | 12 | $1,480 |
| Dutasteride | 28 | $1,146 |
| Spironolactone | 67 | $989 |
| Clobetasol Propionate | 15 | $883 |
| Ketoconazole | 25 | $821 |
| Hydroxychloroquine Sulfate | 12 | $593 |
| Doxycycline Hyclate | 17 | $399 |
| Clindamycin Phosphate | 15 | $368 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Beachwood
- Lydia ParkerBeachwood$36K
- Matthew ZirwasBexley$3.3M
- George DrewMarion$1.9M
- Rocco SerraoDayton$1.7M
- James LibeccoFairlawn$1.1M
- Pranav ShethWest Chester$978K
- Dawn MerrittAthens$844K
- Neil KormanCleveland$824K
- Joshua GrosshandlerWesterville$479K
- Lorie GottwaldToledo$460K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.